Viewing Study NCT03311308


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-03-06 @ 10:10 PM
Study NCT ID: NCT03311308
Status: RECRUITING
Last Update Posted: 2025-05-06
First Post: 2017-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
Sponsor: Yana Najjar
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Melanoma View
None Unresectable View
None Stage III View
None Stage IV View